Mice Model Market Size, Share, and Outlook, H2-2025 Report- By Model Type & Service (Model Type, Service), By Technology (CRISPR/CAS9, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, Others), By Therapeutic Area (Oncology, Metabolic Disea

Mice Model Market Outlook
The global Mice Model Market Size is valued at $1.7 Billion in 2025 and is forecast to reach $2.9 Billion in 2032 at a CAGR of 7.9%.
The Mice Model Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Mice Model Market segments across 22 countries from 2021 to 2032. Key segments covered include By Model Type & Service (Model Type, Service), By Technology (CRISPR/CAS9, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, Others), By Therapeutic Area (Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases, Others), By Application (Drug Discovery & Development, Research Application, Personalized Medicine), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CDMOs, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.

Mice Model Market Insights, 2025
The mice model market in 2025 is witnessing steady transformation driven by advancements in genetic engineering and precision medicine research. Mice continue to be indispensable in preclinical testing due to their genetic similarity to humans and adaptability in modeling complex diseases. CRISPR/Cas9 and other genome-editing techniques have enabled researchers to create highly targeted models for oncology, immunology, and neurodegenerative disorders. The growing focus on rare disease research and gene therapies has further increased reliance on customized transgenic and knockout mouse strains. In addition, the demand for humanized mice is rising as they provide more translational relevance in studying immune system functions and evaluating biologics. Contract research organizations and academic research centers are increasingly investing in specialized mouse colonies to meet evolving study requirements. Ethical considerations and refinement in animal welfare protocols are shaping breeding and housing practices. The mice model industry is also leveraging advanced imaging and digital monitoring to enhance data reliability in preclinical studies.

Five Trends Shaping the Global Mice Model Market in 2025 and Beyond
The global Mice Model Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.

What are the Biggest Opportunities for Growth in the Mice Model Industry?
The Mice Model Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Mice Model Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.

Mice Model Market Segment Insights
The Mice Model Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Model Type & Service (Model Type, Service), By Technology (CRISPR/CAS9, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, Others), By Therapeutic Area (Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases, Others), By Application (Drug Discovery & Development, Research Application, Personalized Medicine), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CDMOs, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.

Mice Model Industry Value Chain
The chapter identifies potential companies and their operations across the global Mice Model Industry ecosystem. It assists decision-makers in evaluating global Mice Model Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.

Scenario Analysis and Forecasts
Strategic planning in the Mice Model Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.

Asia Pacific Mice Model Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Mice Model Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.

United States Mice Model Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Mice Model Market.

Europe Mice Model Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Mice Model Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Mice Model Industry competitiveness. The report analyses the key Mice Model Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.

Latin American Mice Model Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Mice Model Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.

Middle East and Africa Mice Model Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Mice Model Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.

Competitive Landscape – How Mice Model Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Mice Model Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Applied StemCell Inc, Aragen Life Sciences Pvt. Ltd, Biocytogen LLC, Charles River Laboratories International Inc, Creative Animodel, Creative Biolabs, Crescendo Biologics Ltd, Cyagen Biosciences Inc, GemPharmatech Co. Ltd, genOway, Harbour BioMed, Ingenious Targeting Laboratory, Janvier Labs, JOINN Laboratories Co. Ltd, JSR Corp, Marshall BioResources, Ozgene Pty Ltd, PolyGene AG, Shanghai Model Organisms Center Inc, Taconic Biosciences Inc, The Jackson Laboratory, TransCure bioServices, Transgenic Inc, Vivo Bio Tech Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.

Mice Model Market Scope
Leading Segments
By Model Type & Service
Model Type

Inbred Mice

Genetically Engineered Mice

Hybrid/Congenic Mice

Outbred Mice

Service

Breeding

Cryopreservation

Rederivation

Quarantine

Others

By Technology
CRISPR/CAS9
Microinjection
Embryonic Stem cell Injection
Nuclear Transfer
Others
By Therapeutic Area
Oncology
Metabolic Diseases
Immunology
Neurology
Cardiovascular Diseases
Others
By Application
Drug Discovery & Development
Research Application
Personalized Medicine
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs & CDMOs
Others

Leading Companies
Applied StemCell Inc
Aragen Life Sciences Pvt. Ltd
Biocytogen LLC
Charles River Laboratories International Inc
Creative Animodel
Creative Biolabs
Crescendo Biologics Ltd
Cyagen Biosciences Inc
GemPharmatech Co. Ltd
genOway
Harbour BioMed
Ingenious Targeting Laboratory
Janvier Labs
JOINN Laboratories Co. Ltd
JSR Corp
Marshall BioResources
Ozgene Pty Ltd
PolyGene AG
Shanghai Model Organisms Center Inc
Taconic Biosciences Inc
The Jackson Laboratory
TransCure bioServices
Transgenic Inc
Vivo Bio Tech Ltd

Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Reasons to Buy the Report

Make informed decisions with 12-year forecasts across 22 countries and multiple market segments.

Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry.

Gain insights into the competitive landscape, including company profiles, financials, and strategic moves.

Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations.

Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade.

Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions.

Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.

Show more